Showing results (131-140 of 203) with videos related to

Sort By:
Pageof 21
Cancer Treatment and Research Communications|May 13, 2025
Efficacy and safety of upfront radiotherapy with immune checkpoint inhibitors for brain metastasis in non-small cell lung cancerYu Tanaka, Hiroki Izumi, Eri Sugiyama, et al.
Esophagus : Official Journal of the Japan Esophageal Society|January 23, 2020
Therapeutic results of proton beam therapy with concurrent chemotherapy for cT1 esophageal cancer and salvage endoscopic therapy for local recurrenceDaiki Sato, Atsushi Motegi, Tomohiro Kadota, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 18, 2011
Multicenter phase II study of an opioid-based pain control program for head and neck cancer patients receiving chemoradiotherapySadamoto Zenda, Kazuto Matsuura, Hiroyuki Tachibana, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|August 13, 2020
Clinical impact of radiofrequency ablation and stereotactic body radiation therapy for colorectal liver metastasis as local therapies for elderly, vulnerable patientsNaoto Gotohda, Shogo Nomura, Manami Doi, et al.
Journal of Radiation Research|May 3, 2023
Clinical results of proton beam radiotherapy for inoperable stage III non-small cell lung cancer: a Japanese national registry studyHitoshi Tatebe, Hideyuki Harada, Keita Mori, et al.
International Journal of Radiation Oncology, Biology, Physics|October 18, 2016
Multicenter Phase 2 Study of Cisplatin and 5-Fluorouracil With Concurrent Radiation Therapy as an Organ Preservation Approach in Patients With Squamous Cell Carcinoma of the Cervical EsophagusSadamoto Zenda, Takashi Kojima, Ken Kato, et al.
Cancer Medicine|March 6, 2020
The "histological replacement growth pattern" represents aggressive invasive behavior in liver metastasis from pancreatic cancerKazuo Watanabe, Shuichi Mitsunaga, Motohiro Kojima, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|January 11, 2019
Predictive factors for hyperprogressive disease during nivolumab as anti-PD1 treatment in patients with advanced gastric cancerAkinori Sasaki, Yoshiaki Nakamura, Saori Mishima, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 3, 2019
Liver phantom design and dosimetric verification in participating institutions for a proton beam therapy in patients with resectable hepatocellular carcinoma: Japan Clinical Oncology Group trial (JCOG1315C)Teiji Nishio, Hidenobu Tachibana, Yuki Kase, et al.
Practical Radiation Oncology|October 5, 2019
Impact of Proton Beam Irradiation of an Anatomic Subsegment of the Liver for Hepatocellular CarcinomaHidehiro Hojo, Vijay Raturi, Naoki Nakamura, et al.
Pageof 21